First thyroid ablation case in Portugal.
First thyroid ablation case in Portugal and our participation in ISITES 7th Symposium on Parathyroid Fluorescence
First thyroid ablation case in Portugal.
Recapping our experiences from last week: we successfully performed the first thyroid ablation case in Portugal under the leadership of Dr. Teresa Dionísio. A heartfelt thank you for your steadfast support in our treatment!”
Our participation in the 7th ISITES Symposium on parathyroid fluorescence
We also had the privilege of participating at the ISITES 7th Symposium on Parathyroid Fluorescence, we’re proud to have partnered with Cardiolink in raising awareness about thyroid treatment through minimally invasive techniques like Radio Frequency ablation with the AJ-500A, demonstrating that fighting thyroid issues no longer has to mean painful surgery— a safe and efficient alternative.
During the symposium, we highlighted the capabilities of the AJ-500A and the advantages it brings to both patients and practitioners. Surgeons had the opportunity to familiarize themselves with the device’s intuitive touchscreen, which allows easy parameter adjustments for various modes, including M-mode (Moving Shot Technique) and P-mode (Pulse Mode) with internal cooling electrodes. Additionally, we presented the A-track mode (affusion) or TEMP mode (Temperature Control) , which operates with a water-injection electrode for enhanced precision and safety.
We appreciate the interest and engagement from surgeons and medical professionals at the symposium, joining the ranks of other professionals who support thyroid ablation with Radio Frequency. If you would like to learn more about how the AJ-500A can enhance your practice, feel free to reach out to us and register for a workshop on the treatment visit the follow link and learn more about our scheduled dates.
Learn about the Sphera
We’re excited to announce the launch of the Sphera! After months of hard work, it’s finally here, and we can’t wait for you to try it. Designed with a spherical end and coated with chromium nitride, Sphera ensures a smooth, non-stick experience on delicate tissue while effectively delivering radiofrequency energy. Therefore this advanced device is now available to treat patients with early-stage internal haemorrhoids (Grade I and II) using radiofrequency thermocoagulation. In conclusion this minimally invasive method uses high-frequency electromagnetic waves (4 MHz) to provide fast, effective relief, ensuring a smoother recovery process.
Why Sphera?
For Practitioners:
- Minimal post-operative wound care – A less invasive approach that ensures faster recovery and greater convenience for your patients.
- Quick and effective – Designed to deliver optimal results with precision, speed, and efficiency, improving patient outcomes.
- Safe procedure – A trusted, reliable, and minimally invasive treatment option for haemorrhoids, prioritizing patient comfort and safety.
For Patients:
Swift relief – Experience rapid and effective relief with a significantly reduced recovery time, allowing patients to return to daily activities sooner.
Minimal discomfort – A gentler, less painful treatment option that promotes a smoother and faster healing process for improved patient comfort.
How it works:
- First insert the anoscope into the patient’s rectum to locate the haemorrhoid.
- Moving forward, apply gentle pressure with the Sphera probe to the haemorrhoid surface, then activate the radiofrequency energy by pressing the foot pedal.
- Next Administer up to 500 joules which is the recommended energy for optimal results.
- Subsequently watch the haemorrhoid react by contracting and whitening.
- Ultimately cool the treated area with a compress soaked in cold saline to stop the heating process.
To summarize, with Sphera, you can provide your patients with an innovative and efficient solution for early-stage internal haemorrhoids.
In fact it’s a game-changing step forward in haemorrhoid care so don’t miss the opportunity to offer your patients the latest advancement in haemorrhoid treatment.
We are excited to announce that Southmedic has joined our network as our new distributor in Canada. This partnership marks the beginning of our presence in the Canadian market.
Michael’s recent visit to Southmedic ensured their team is well-prepared to deliver our high standards of service and product knowledge, equipped with the expertise necessary to support our products and meet our customers’ needs.
With their dedicated team now fully trained and ready, Southmedic is well-prepared to deliver our high standards of service and product knowledge to our Canadian customers. We are confident that this collaboration will bring exceptional value and service to the Canadian healthcare community.
Join us in welcoming Southmedic to our family. We anticipate a fruitful and successful partnership ahead.
Two instructive masterclasses on the Rafaelo procedure recently took place in Delhi and Mumbai, bringing together experts and students alike.
In Mumbai, at the Global Hospital in Parel, Dr. Carlo Vivaldi from Germany shared valuable insights into the Rafaelo RF ablation procedure for treating haemorrhoids. The session included a live case demonstration skilfully performed by Dr. Jignesh Gandhi.
In Delhi, at Maulana Azad Medical College (MAMC), more than 50 specialists and 30 students gathered for the Masterclass.
Dr Jignesh Gandhi and Dr Carlo Vivaldi demonstrated their expertise in using the Rafaelo technique. In just 3 hours, they treated seven patients, each with at least three haemorrhoids, as well as an additional case with an anal fistula.
Dr. Pawanindra Lal, Director Professor, and Head of Surgery at MAMC & Lok Nayak Hospital played a pivotal role in spearheading and organising this transformative event.
We are pleased to inform you about our participation at Medica, the prominent trade fair for the medical industry, scheduled from November 13th to November 16th in Düsseldorf.
Don’t miss this opportunity to connect with us and discover the latest advancements in medical RF technology. You can find us at the Belgium pavilion in Hall 15, Booth C16. Looking forward to meeting you!
Available from today, this all-inclusive Fistura Pack is a complete set of supplies for the treatment of anal fistulas.
A French prospective multicentre study assessed RFA (Rafaelo®) in 129 outpatients with grade II–III haemorrhoids with a 1 year follow up.
16 Centres participated in the research. RFA was performed in the operating room under locoregional or general anaesthesia. Primary endpoint was the evolution of a quality-of-life score adapted to the haemorrhoid pathology (HEMO-FISS-QoL) 3 months after surgery. Secondary endpoints were evolution of symptoms, complications, postoperative pain and medical leave.
The researchers concluded that RFA is associated with an improvement in quality of life and symptoms with a good safety profile. As expected for minimally invasive surgery, postoperative pain is minor with short medical leave. They pointed out that regarding average operating times, RFA is more rapid (15 min) than other techniques.
The U.S. Food and Drug Administration (FDA) has approved the HPR45i electrosurgical electrode to conduct radiofrequency (RF) current for coagulation from the RF electrosurgical generator MedRF4000® to target soft tissue in a broad range of surgical procedures.